|
08/10/2015 |
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
CIM |
Registered |
|
23/12/2016 |
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus |
CIM |
Registered |
|
08/04/2015 |
Combifer vs Trofin phase II in anemic pregnant women. |
BIOCEN |
Registered |
|
12/05/2015 |
Vitamin E/ Platinum salts |
CIDEM |
Registered |
|
13/04/2015 |
Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II |
BIOCEN |
Registered |
|
13/04/2015 |
Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. |
BIOCEN |
Registered |
|
08/04/2015 |
THERESA-5 Study |
CIGB |
Registered |
|
22/05/2015 |
Safety and pharmacokinetics of CIGB-552 |
CIGB |
Registered |
|
04/10/2023 |
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana |
FINLAY |
Registered |
|
25/09/2015 |
Seawater-Rhinitis-Children-Phase III |
UDEA |
Registered |
|
08/07/2015 |
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer |
CIM |
Registered |
|
24/06/2015 |
SURFACEN in ARDS. Adults. Phase IV |
CENSA |
Registered |
|
15/12/2015 |
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients |
CIM |
Registered |
|
15/08/2017 |
Phenamate in the treatment of prostate cancer |
SSA |
Registered |
|
11/03/2016 |
Dermofural-diabetic foot ulcers |
CBQ |
Registered |
|
05/09/2017 |
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma |
CIM |
Registered |
|
22/05/2020 |
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 |
FINLAY |
Registered |
|
16/02/2017 |
Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II |
HGM |
Registered |
|
02/12/2016 |
Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months. |
CPN |
Registered |
|
28/11/2016 |
Abexol and Atorvastatin in the non alcoholic steatohepatitis |
CPN |
Registered |
